Crick Institute researcher details interferon's dual role in lung infections

In a 58-minute expert talk for Global ImmunoTalks, a researcher from the Francis Crick Institute studying host determinants of respiratory infection severity argued that interferon is not simply protective in lung infection. Focusing on interferon and inflammation, lung epithelial and endothelial biology, and type I/II interferons in immunopathology and tissue repair, the speaker described how interferon can also drive immune pathology and tissue damage, and how acute infection can leave long-term effects on lung immunity. The central claim is that heterogeneous infection outcomes are determined by host factors rather than antiviral responses alone, reframing interferon as a pathway with both protective and pathological consequences depending on context.

Written by a model from the reports

Not enough continuous observation yet to draw a trend.